Stem Cells: Panacea or Pandora's Box?

McCaffrey, Ryan M.
April 2008
Harvard Salient;4/24/2008, p8
The article discusses the dispute over the issue of using human embryonic stem (ES) in research. The benefit of ES research is said to be infinite for the improvement of clinical treatments of various medical conditions. Critics of ES cell research argue that it is a degradation of human life despite the fact that it presents the possibility of preserving other living human beings.


Related Articles

  • Human iPS Cells: Science and Ethics. Crook, Jeremy Micah // Open Stem Cell Journal;2010 Special Issue, p1 

    An introduction to the journal is presented in which the editor discusses articles on the science and ethic of human induced pluripotent stem (iPS) cells, the human somatic cell reprogramming, and the biological equivalent of the iPS and embryonic stem (ES) cells.

  • COMPLICITY AND STEM CELL RESEARCH: COUNTERING THE UTILITARIAN ARGUMENT. SULLIVAN, DENNIS M.; COSTERISAN, AARON // Ethics & Medicine: An International Journal of Bioethics;Fall2008, Vol. 24 Issue 3, p151 

    The article discusses the moral complicity within stem cell research. It notes that those who advocate the killing of an embryonic human being for such research can be regarded as having complicity with a moral evil, provided that personhood of the embryo is assumed. It adds that pro-life...

  • Only Human. Sullivan, Andrew // Human Life Review;Summer2001, Vol. 27 Issue 3, p48 

    Evaluates stem-cell research in the United States. Description of a scene from the motion picture 'A.I.,'; Moral implications of blastocysts; Criterion of a human being.

  • President Reagan Would Have Opposed ESCR. Thomas, Cal // Human Life Review;Summer2001, Vol. 27 Issue 3, p51 

    Examines the opposition of Ronald Reagan embryonic stem cell research in the United States. Defense of human life; Banning of human cloning; Flexibility of federal regulation.

  • Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Liu, Xiaosong; Huang, Jinyan; Chen, Taotao; Wang, Ying; Xin, Shunmei; Li, Jian; Pei, Gang; Kang, Jiuhong // Cell Research;Dec2008, Vol. 18 Issue 12, p1177 

    Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) are highly expressed in embryonic stem (ES) cells, and their over-expression can induce pluripotency in both mouse and human somatic cells, indicating that these factors regulate the developmental signaling network necessary for ES cell pluripotency....

  • Engineered embryonic stem cells for regnerative nedicine. Hescheler, J. // Cell Research;Aug2008 Supplement, Vol. 18, pS111 

    Due to their ability to reproduce the embryological differentiation of nearly all different cellular phenotypes, embryonic stem (ES) cells represent an ideal tool to study processes of embryogenesis under in vitro conditions, in particular the signalling cascades and genes involved in the...

  • Stem Cell Research: An Overview. Farrell, Courtney; Carson-Dewitt, Rosalyn // Points of View: Stem Cell Research;12/31/2017, p1 

    Embryonic stem cells are undifferentiated cells that show promise in the treatment of heart disease, cancer, spinal cord injuries, diabetes, Alzheimer's disease, schizophrenia, ALS, autism, obesity, osteoporosis, and Parkinson's disease. For example, if stem cells are introduced into a patient's...

  • Research on embryonic stem cells: The time has come--maybe. Asch-Goodkin, Judith // Contemporary Pediatrics;Jun2005, Vol. 22 Issue 6, p12 

    This article looks at efforts to fund research on embryonic stem cells in the U.S. Embryonic stem cells have enormous therapeutic potential for a wide range of diseases and disabilities but, unhappily, existing techniques for extracting these amazing cells kill the embryo that contains them....

  • The 110th Congress can end debate about embryonic stem cell research. Bartlett, Roscoe // Hill;1/22/2008, Vol. 15 Issue 6, p15 

    The article focuses on the call to end the embryonic stem cell research controversy in the U.S. The author believes that it is not necessary to spend federal taxpayer money to sacrifice the life of human embryos to advance embryonic stem cell research. He stresses that the research violates the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics